Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00656474 · ClinicalTrials.gov registry record · Phase 1
Efficacy Study of GLYC-101 to Evaluate Outcomes After Post-laser Ablation
A Phase 1 study, sponsored by TR Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT00656474 is a Phase 1 study that has completed, run by TR Therapeutics. The registered enrollment target is 12 participants.
The verdict
NCT00656474, a Phase 1 study, has completed, sponsored by TR Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
Study is intended to evaluate safety and efficacy parameters in patients treated with GLYC-101 gel or placebo after laser ablation.
Interventions
- DRUG Placebo gel
- DRUG GLYC-101 gel (1.0 %)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00656474
The ClinicalTrials.gov registry entry for NCT00656474 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TR Therapeutics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo gel is the first listed.
NCT00656474 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00656474 about?
NCT00656474 is a clinical study titled "Efficacy Study of GLYC-101 to Evaluate Outcomes After Post-laser Ablation". Study is intended to evaluate safety and efficacy parameters in patients treated with GLYC-101 gel or placebo after laser ablation.
What is the current status of trial NCT00656474?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2008-03. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00656474?
The interventions under investigation include: Placebo gel (DRUG), GLYC-101 gel (1.0 %) (DRUG).
Who is sponsoring clinical trial NCT00656474?
This trial is sponsored by TR Therapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.